Cargando…

Neurocysticercosis: Current Perspectives on Diagnosis and Management

Porcine cysticercosis, human taeniasis, and (neuro)cysticercosis are endemic in many low- and middle-income countries (LMIC) where they present a significant health burden to affected communities. Neurocysticercosis (NCC) is one of the leading causes of human epilepsy in many hyperendemic regions in...

Descripción completa

Detalles Bibliográficos
Autores principales: Butala, Caitlin, Brook, T. M., Majekodunmi, Ayodele O., Welburn, Susan Christina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141574/
https://www.ncbi.nlm.nih.gov/pubmed/34041288
http://dx.doi.org/10.3389/fvets.2021.615703
_version_ 1783696390194462720
author Butala, Caitlin
Brook, T. M.
Majekodunmi, Ayodele O.
Welburn, Susan Christina
author_facet Butala, Caitlin
Brook, T. M.
Majekodunmi, Ayodele O.
Welburn, Susan Christina
author_sort Butala, Caitlin
collection PubMed
description Porcine cysticercosis, human taeniasis, and (neuro)cysticercosis are endemic in many low- and middle-income countries (LMIC) where they present a significant health burden to affected communities. Neurocysticercosis (NCC) is one of the leading causes of human epilepsy in many hyperendemic regions in Latin America, Asia, and sub-Saharan Africa. The World Health Organization (WHO) reports an estimated 2.5–8.3 million cases of NCC annually with a disability-adjusted life year (DALY) burden of 2.8 million, but as for all neglected tropical diseases (NTDs), these values are likely to be underestimated. Diagnosis of NCC is complex and most accurately diagnosed using clinical neuroimaging that is unavailable in most hyperendemic regions in LMIC. On January 28, 2021, WHO will launch its road map for the NTDs' “Ending the neglect to attain the Sustainable Development Goals: a road map for neglected tropical diseases 2021–2030.” Taeniasis/cysticercosis is targeted for control success considered as steady increase in the number of countries with intensified control in hyperendemic areas [increasing from 2 (3%) in 2020 to 4 (6%) in 2023, to 9 (14%) by 2025, and to 17 (27%) by 2030]. Cross-cutting targets that include 100% access to at least basic water supply, sanitation, and hygiene in areas endemic for NTDs and 75% integrated treatment coverage for preventative chemotherapy will additionally impact on the taeniasis/cysticercosis/NCC complex. With no vaccine available for humans, prevention of infection depends on communication to the public of the life cycle of a complex zoonosis to promote behavior change, underpinned by practical control measures including treatment of human taeniasis and (neuro)cysticercosis with albendazole and praziquantel [widely used as part of the mass drug administration (MDA) deworming programs], surgery where appropriate, and effective vaccination and deworming for pigs supported by meat inspection. Here, we review recent advances in tools and implementation for Taenia solium taeniasis/(neuro)cysticercosis (TSTC) control and milestones on the onward path to elimination.
format Online
Article
Text
id pubmed-8141574
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-81415742021-05-25 Neurocysticercosis: Current Perspectives on Diagnosis and Management Butala, Caitlin Brook, T. M. Majekodunmi, Ayodele O. Welburn, Susan Christina Front Vet Sci Veterinary Science Porcine cysticercosis, human taeniasis, and (neuro)cysticercosis are endemic in many low- and middle-income countries (LMIC) where they present a significant health burden to affected communities. Neurocysticercosis (NCC) is one of the leading causes of human epilepsy in many hyperendemic regions in Latin America, Asia, and sub-Saharan Africa. The World Health Organization (WHO) reports an estimated 2.5–8.3 million cases of NCC annually with a disability-adjusted life year (DALY) burden of 2.8 million, but as for all neglected tropical diseases (NTDs), these values are likely to be underestimated. Diagnosis of NCC is complex and most accurately diagnosed using clinical neuroimaging that is unavailable in most hyperendemic regions in LMIC. On January 28, 2021, WHO will launch its road map for the NTDs' “Ending the neglect to attain the Sustainable Development Goals: a road map for neglected tropical diseases 2021–2030.” Taeniasis/cysticercosis is targeted for control success considered as steady increase in the number of countries with intensified control in hyperendemic areas [increasing from 2 (3%) in 2020 to 4 (6%) in 2023, to 9 (14%) by 2025, and to 17 (27%) by 2030]. Cross-cutting targets that include 100% access to at least basic water supply, sanitation, and hygiene in areas endemic for NTDs and 75% integrated treatment coverage for preventative chemotherapy will additionally impact on the taeniasis/cysticercosis/NCC complex. With no vaccine available for humans, prevention of infection depends on communication to the public of the life cycle of a complex zoonosis to promote behavior change, underpinned by practical control measures including treatment of human taeniasis and (neuro)cysticercosis with albendazole and praziquantel [widely used as part of the mass drug administration (MDA) deworming programs], surgery where appropriate, and effective vaccination and deworming for pigs supported by meat inspection. Here, we review recent advances in tools and implementation for Taenia solium taeniasis/(neuro)cysticercosis (TSTC) control and milestones on the onward path to elimination. Frontiers Media S.A. 2021-05-10 /pmc/articles/PMC8141574/ /pubmed/34041288 http://dx.doi.org/10.3389/fvets.2021.615703 Text en Copyright © 2021 Butala, Brook, Majekodunmi and Welburn. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Veterinary Science
Butala, Caitlin
Brook, T. M.
Majekodunmi, Ayodele O.
Welburn, Susan Christina
Neurocysticercosis: Current Perspectives on Diagnosis and Management
title Neurocysticercosis: Current Perspectives on Diagnosis and Management
title_full Neurocysticercosis: Current Perspectives on Diagnosis and Management
title_fullStr Neurocysticercosis: Current Perspectives on Diagnosis and Management
title_full_unstemmed Neurocysticercosis: Current Perspectives on Diagnosis and Management
title_short Neurocysticercosis: Current Perspectives on Diagnosis and Management
title_sort neurocysticercosis: current perspectives on diagnosis and management
topic Veterinary Science
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141574/
https://www.ncbi.nlm.nih.gov/pubmed/34041288
http://dx.doi.org/10.3389/fvets.2021.615703
work_keys_str_mv AT butalacaitlin neurocysticercosiscurrentperspectivesondiagnosisandmanagement
AT brooktm neurocysticercosiscurrentperspectivesondiagnosisandmanagement
AT majekodunmiayodeleo neurocysticercosiscurrentperspectivesondiagnosisandmanagement
AT welburnsusanchristina neurocysticercosiscurrentperspectivesondiagnosisandmanagement